Karyopharm Therapeutics | KPTI - القيمة السوقية





القيمة السوقية تغيير تاريخ
AbbVie USD 403.83B 5.2B 2025-12
Abbott USD 217.86B 15.25B 2025-12
Amgen USD 176.25B 24.32B 2025-12
AstraZeneca USD 220.14B 68B 2026-03
BioCryst Pharmaceuticals USD 1.7B 40M 2026-03
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Enanta Pharmaceuticals USD 122M 98M 2024-12
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
Incyte USD 19.39B 2.83B 2025-12
J&J USD 500.24B 67.44B 2025-12
MacroGenics USD 192M 90M 2026-03
Merck USD 261.26B 51.62B 2025-12
Novartis USD 240.48B 51.73B 2026-03
Novartis USD 303.66B 40.58B 2026-03
Pfizer USD 153.96B 12.4B 2026-03
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Takeda JPY 7.64T 774.9B 2025-12
Tectonic Therapeutic USD 474M 84M 2026-03
TG Therapeutics USD 4.73B 1B 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Xencor USD 1.09B 256M 2025-12